{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:09:25Z","timestamp":1778602165564,"version":"3.51.4"},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0477_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The rise in obesity has led to a higher incidence of metabolic diseases in children. Overnutrition leads to increased intake and availability of tryptophan (TRP). Research indicates a link between indoleamine 2,3-dioxygenase (IDO) activity, the activation of the tryptophan catabolic pathway, and inflammation associated with obesity. This study investigated how pediatric obesity affects tryptophan metabolism and its potential link to metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0477_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study included 86 children aged 10\u00a0years and older, 56 of whom were obese. Obese children with body mass index (BMI) &gt;95th percentile were divided into two groups: obese (BMI greater than 120\u202f% of the 95th percentile for age and sex) and severely obese (BMI greater than 140\u202f% of the 95th percentile for age and sex). Serum levels of kynurenine pathway metabolites were determined by liquid chromatography-mass spectrometry\/mass spectrometry system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0477_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean ages (13.6 and 13.2 years) and gender distribution (36.7 and 46.2\u202f% male) were similar across the groups. There were significant differences in tryptophan levels between the groups, being higher in the obese groups (p&lt;0.001). 3-hydroxykynurenine (3HK) was significantly higher in the obese group (p=0.029). 3-hydroxykynurenine\/kynurenine (3HK\/KYN) ratio also significantly correlated with increased GGT and triglyceride levels and low HDL. Also higher 3HK\/KYN ratio was correlated with elevated systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels. No significant relationship was found between the KYN\/TRP ratio and obesity metabolic syndrome indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0477_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although plasma kynurenine pathway metabolites showed some changes in children with obesity, larger series studies are needed to determine the relationship with metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0477","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:18:48Z","timestamp":1761844728000},"page":"1278-1285","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the kynurenine pathway in pediatric metabolic health"],"prefix":"10.1515","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-3480","authenticated-orcid":false,"given":"Fatma","family":"\u00d6zg\u00fc\u00e7 \u00c7\u00f6mlek","sequence":"first","affiliation":[{"name":"485663 Sel\u00e7uk \u00dcniversity, Medical Faculty, Pediatric Endocrinology , Konya , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-9205","authenticated-orcid":false,"given":"Dilek","family":"Bing\u00f6l Ayd\u0131n","sequence":"additional","affiliation":[{"name":"Tatvan Statete Hospital, Pediatric Endocrinology Clinic , Bitlis , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikret","family":"Aky\u00fcrek","sequence":"additional","affiliation":[{"name":"Sel\u00e7uk \u00dcniversity, Medical Faculty, Biochemistry , Konya , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muslu Kaz\u0131m","family":"K\u00f6rez","sequence":"additional","affiliation":[{"name":"Sel\u00e7uk \u00dcniversity, Medical Faculty, Biostatistics , Konya , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuat","family":"Bu\u011frul","sequence":"additional","affiliation":[{"name":"485663 Sel\u00e7uk \u00dcniversity, Medical Faculty, Pediatric Endocrinology , Konya , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2026051215122188000_j_jpem-2025-0477_ref_001","doi-asserted-by":"crossref","unstructured":"Weihrauch-Bl\u00fcher, S, Schwarz, P, Klusmann, JH. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism 2019;92:147\u201352. https:\/\/doi.org\/10.1016\/j.metabol.2018.12.001.","DOI":"10.1016\/j.metabol.2018.12.001"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_002","doi-asserted-by":"crossref","unstructured":"Caprio, S, Santoro, N, Weiss, R. Childhood obesity and the associated rise in cardiometabolic complications. Nat Metab 2020;2:223\u201332. https:\/\/doi.org\/10.1038\/s42255-020-0183-z.","DOI":"10.1038\/s42255-020-0183-z"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_003","doi-asserted-by":"crossref","unstructured":"Nadeau, KJ, Maahs, DM, Daniels, SR, Eckel, RH. Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol 2011;8:513\u201325. https:\/\/doi.org\/10.1038\/nrcardio.2011.86.","DOI":"10.1038\/nrcardio.2011.86"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_004","doi-asserted-by":"crossref","unstructured":"Vukovic, R, Dos Santos, TJ, Ybarra, M, Atar, M. Children with metabolically healthy obesity: a review. Front Endocrinol 2019;10:865. https:\/\/doi.org\/10.3389\/fendo.2019.00865.","DOI":"10.3389\/fendo.2019.00865"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_005","doi-asserted-by":"crossref","unstructured":"Damanhoury, S, Newton, AS, Rashid, M, Hartling, L, Byrne, JLS, Ball, GDC. Defining metabolically healthy obesity in children: a scoping review. Obes Rev 2018;19:1476\u201391. https:\/\/doi.org\/10.1111\/obr.12721.","DOI":"10.1111\/obr.12721"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_006","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher, M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009;117:241\u201350. https:\/\/doi.org\/10.1055\/s-0029-1192044.","DOI":"10.1055\/s-0029-1192044"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_007","doi-asserted-by":"crossref","unstructured":"Maury, E, Brichard, S. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1\u201316. https:\/\/doi.org\/10.1016\/j.mce.2009.07.031.","DOI":"10.1016\/j.mce.2009.07.031"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_008","doi-asserted-by":"crossref","unstructured":"de Heredia, FP, G\u00f3mez-Mart\u00ednez, S, Marcos, A. Obesity, inflammation and the immune system. Proc Nutr Soc 2012;71:332\u20138. https:\/\/doi.org\/10.1017\/s0029665112000092.","DOI":"10.1017\/S0029665112000092"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_009","doi-asserted-by":"crossref","unstructured":"Bernard, A, Le May, C, Dastugue, A, Ayer, A, Blanchard, C, Martin, JC, et al.. The tryptophan\/kynurenine pathway: a novel cross-talk between nutritional obesity, bariatric surgery and taste of fat. Nutrients 2021;13:1366. https:\/\/doi.org\/10.3390\/nu13041366.","DOI":"10.3390\/nu13041366"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_010","doi-asserted-by":"crossref","unstructured":"Liu, JJ, Movassat, J, Portha, B. Emerging role for kynurenines in metabolic pathologies. Curr Opin Clin Nutr Metab Care 2019;22:82\u201390. https:\/\/doi.org\/10.1097\/mco.0000000000000529.","DOI":"10.1097\/MCO.0000000000000529"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_011","doi-asserted-by":"crossref","unstructured":"Brandacher, G, Hoeller, E, Fuchs, D, Weiss, H. Chronic immune activation underlies morbid obesity: is IDO A key player? Curr Drug Metabol 2007;8:289\u201395. https:\/\/doi.org\/10.2174\/138920007780362590.","DOI":"10.2174\/138920007780362590"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_012","doi-asserted-by":"crossref","unstructured":"Strasser, B, Berger, K, Fuchs, D. Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults. Eur J Nutr 2014;54:101\u20137. https:\/\/doi.org\/10.1007\/s00394-014-0690-3.","DOI":"10.1007\/s00394-014-0690-3"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_013","doi-asserted-by":"crossref","unstructured":"Badawy, AA, Guillemin, G. The plasma [Kynurenine]\/[Tryptophan] ratio and indoleamine 2,3-Dioxygenase: time for appraisal. Int J Tryptophan Res 2019;12, 1178646919868978. https:\/\/doi.org\/10.1177\/1178646919868978.","DOI":"10.1177\/1178646919868978"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_014","doi-asserted-by":"crossref","unstructured":"Miura, H, Ozaki, N, Sawada, M, Isobe, K, Ohta, T, Nagatsu, T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 2008;11:198\u2013209. https:\/\/doi.org\/10.1080\/10253890701754068.","DOI":"10.1080\/10253890701754068"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_015","doi-asserted-by":"crossref","unstructured":"Chaves Filho, AJM, Lima, CNC, Vasconcelos, SMM, de Lucena, DF, Maes, M, Macedo, D. IDO chronic immune activation and tryptophan metabolic pathway: a potential pathophysiological link between depression and obesity. Prog Neuropsychopharmacol Biol Psychiatry 2018;80:234\u201349. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.035.","DOI":"10.1016\/j.pnpbp.2017.04.035"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_016","doi-asserted-by":"crossref","unstructured":"Mangge, H, Summers, KL, Meinitzer, A, Zelzer, S, Almer, G, Prassl, R, et al.. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity (Silver Spring) 2014;22:195\u2013201. https:\/\/doi.org\/10.1002\/oby.20491.","DOI":"10.1002\/oby.20491"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_017","doi-asserted-by":"crossref","unstructured":"Favennec, M, Hennart, B, Caiazzo, R, Leloire, A, Yengo, L, Verbanck, M, et al.. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity (Silver Spring) 2015;23:2066\u201374. https:\/\/doi.org\/10.1002\/oby.21199.","DOI":"10.1002\/oby.21199"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_018","doi-asserted-by":"crossref","unstructured":"Yu, E, Papandreou, C, Ruiz-Canela, M, Guasch-Ferre, M, Clish, CB, Dennis, C, et al.. Association of tryptophan metabolites with incident type 2 diabetes in the PREDIMED trial: a case-cohort study. Clin Chem 2018;64:1211\u201320. https:\/\/doi.org\/10.1373\/clinchem.2018.288720.","DOI":"10.1373\/clinchem.2018.288720"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_019","doi-asserted-by":"crossref","unstructured":"Rebnord, EW, Strand, E, Midttun, \u00d8, Svingen, GFT, Christensen, MHE, Ueland, PM, et al.. The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease. Diabetologia 2017;60:1712\u201321. https:\/\/doi.org\/10.1007\/s00125-017-4329-9.","DOI":"10.1007\/s00125-017-4329-9"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_020","doi-asserted-by":"crossref","unstructured":"Rojas, IY, Moyer, BJ, Ringelberg, CS, Wilkins, OM, Pooler, DB, Ness, DB, et al.. Kynurenine-induced aryl hydrocarbon receptor signaling in mice causes body mass gain, liver steatosis, and hyperglycemia. Obesity 2021;29:337\u201349. https:\/\/doi.org\/10.1002\/oby.23065.","DOI":"10.1002\/oby.23065"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_021","doi-asserted-by":"crossref","unstructured":"Deac, OM, Mills, JL, Shane, B, Midttun, \u00d8, Ueland, PM, Brosnan, JT, et al.. Tryptophan catabolism and vitamin B-6 status are affected by gender\u00a0and lifestyle factors in healthy young adults. J\u00a0Nutr 2015;145:701\u20137. https:\/\/doi.org\/10.3945\/jn.114.203091.","DOI":"10.3945\/jn.114.203091"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_022","doi-asserted-by":"crossref","unstructured":"Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291\u2013303. https:\/\/doi.org\/10.1136\/adc.44.235.291.","DOI":"10.1136\/adc.44.235.291"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_023","doi-asserted-by":"crossref","unstructured":"\u00d6zt\u00fcrk, A, Borlu, A, \u00c7i\u00e7ek, B 0\u201318 ya\u015f \u00e7ocuk ve adolesanlarda b\u00fcy\u00fcme e\u011frileri. T\u00fcrk Aile Hek Der 2011;15:112\u20139.","DOI":"10.2399\/tahd.11.112"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_024","doi-asserted-by":"crossref","unstructured":"Skinner, AC, Ravanbakht, SN, Skelton, JA, Perrin, EM, Armstrong, SC. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics 2018;141:e20173459. https:\/\/doi.org\/10.1542\/peds.2017-3459.","DOI":"10.1542\/peds.2017-3459"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_025","doi-asserted-by":"crossref","unstructured":"Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC. Homeostasis model assessment: In-Sulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u201319. https:\/\/doi.org\/10.1007\/bf00280883.","DOI":"10.1007\/BF00280883"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_026","doi-asserted-by":"crossref","unstructured":"Zimmet, P, Alberti, KG, Kaufman, F, Tajima, N, Silink, M, Arslanian, S, et al.. The metabolic syndrome in children and adolescents\u2013an IDF consensus report. Pediatr Diabetes 2007;8:299\u2013306. https:\/\/doi.org\/10.1111\/j.1399-5448.2007.00271.x.","DOI":"10.1111\/j.1399-5448.2007.00271.x"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_027","doi-asserted-by":"crossref","unstructured":"Tong, Q, Song, J, Yang, G, Fan, L, Xiong, W, Fang, J. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS\/MS and its application to acute myocardial infarction monitoring. Biomed Chromatogr 2018;32:e4156. https:\/\/doi.org\/10.1002\/bmc.4156.","DOI":"10.1002\/bmc.4156"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_028","doi-asserted-by":"crossref","unstructured":"Lischka, J, Schanzer, A, Baumgartner, M, de Gier, C, Greber-Platzer, S, Zeyda, M. Tryptophan metabolism is associated with BMI and adipose tissue mass and linked to metabolic disease in pediatric obesity. Nutrients 2022;14:286. https:\/\/doi.org\/10.3390\/nu14020286.","DOI":"10.3390\/nu14020286"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_029","doi-asserted-by":"crossref","unstructured":"Tan, KM, Tint, MT, Kothandaraman, N, Yap, F, Godfrey, KM, Lee, YS, et al.. Association of plasma kynurenine pathway metabolite concentrations with metabolic health risk in prepubertal Asian children. Int J Obes 2022;46:1128\u201337. https:\/\/doi.org\/10.1038\/s41366-022-01085-4.","DOI":"10.1038\/s41366-022-01085-4"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_030","doi-asserted-by":"crossref","unstructured":"Kubacka, J, Staniszewska, M, Sadok, I, Sypniewska, G, Stefanska, A. The kynurenine pathway in Obese middle-aged women with normoglycemia and type 2 diabetes. Metabolites 2022;12:492. https:\/\/doi.org\/10.3390\/metabo12060492.","DOI":"10.3390\/metabo12060492"},{"key":"2026051215122188000_j_jpem-2025-0477_ref_031","doi-asserted-by":"crossref","unstructured":"Valente-Silva, P, Cervenka, I, Ferreira, DMS, Correia, JC, Edman, S, Horwath, O, et al.. Effects of tryptophan supplementation and exercise on the fate of kynurenine metabolites in mice and humans. Metabolites 2021;11. https:\/\/doi.org\/10.3390\/metabo11080508.","DOI":"10.3390\/metabo11080508"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0477\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0477\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:13:21Z","timestamp":1778598801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0477\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,10,13]]},"published-print":{"date-parts":[[2025,12,17]]}},"alternative-id":["10.1515\/jpem-2025-0477"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0477","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}